10 | InterferonsIBA
03/2014
-
12/2005 |
7 | Ribavirin (Virazole)FDA LinkGeneric
03/2014
-
02/2006 |
2 | Fluorouracil (Carac)FDA LinkGeneric
01/2019
-
01/2011 |
2 | GemcitabineFDA Link
11/2018
-
03/2008 |
2 | RNA (Ribonucleic Acid)IBA
09/2010
-
07/2007 |
2 | Interferon-alpha (Interferon Alfa)IBA
10/2009
-
12/2005 |
1 | Biomarkers (Surrogate Marker)IBA
06/2021 |
1 | Therapeutic UsesIBA
06/2021 |
1 | SulfurIBA
01/2021 |
1 | AcidsIBA
05/2019 |
1 | PotassiumIBA
05/2019 |
1 | PlatinumIBA
01/2019 |
1 | human ERBB2 proteinIBA
01/2019 |
1 | Trastuzumab (Herceptin)FDA Link
01/2019 |
1 | Polyglycolic Acid (Polyglycolide)IBA
01/2019 |
1 | Paclitaxel (Taxol)FDA LinkGeneric
01/2019 |
1 | 130-nm albumin-bound paclitaxelIBA
11/2018 |
1 | folfirinoxIBA
11/2018 |
1 | Pepsinogen A (Pepsinogen)IBA
07/2015 |
1 | LipidsIBA
05/2013 |
1 | rat MIRN27 microRNAIBA
05/2013 |
1 | Transcription Factors (Transcription Factor)IBA
05/2013 |
1 | (2E,4E,6E,10E)- 3,7,11,15- tetramethyl- 2,4,6,10,14- hexadecapentaenoic acidIBA
04/2013 |
1 | 3,7,11,15- tetramethyl- 2,4,6,10,14- hexadecapentaenoic acidIBA
04/2013 |
1 | Antiviral Agents (Antivirals)IBA
04/2013 |
1 | Mechanistic Target of Rapamycin Complex 1IBA
07/2011 |
1 | AntigensIBA
04/2011 |
1 | Cisplatin (Platino)FDA LinkGeneric
01/2011 |
1 | InterleukinsIBA
08/2010 |
1 | Glycoproteins (Glycoprotein)IBA
07/2007 |
1 | AntibodiesIBA
07/2007 |
1 | Neutralizing AntibodiesIBA
07/2007 |
1 | Mycophenolic Acid (Cellcept)FDA LinkGeneric
02/2006 |